COVID-19 相关肩带钙化性肌炎:一种新疾病实体
本研究回顾了 2020 年 4 月至 2021 年 7 月三个时段共 1201 例患者的 1239 次 CT 肺动脉造影检查,识别出 COVID-19 相关肩带钙化性肌炎患者,总体患病率为 1.3%,最常见部位为肩胛下肌。作者认为早期识别和提高对该疾病的认识有助于降低患者发病率并改善长期功能结局。
要点
- COVID-19 相关肩带钙化性肌炎是罕见的肺外肌肉骨骼表现,总体患病率 1.3%。
- 最常见累及部位为肩胛下肌,阅片时需注意肩带肌群钙化灶。
- 作者经验认为早期识别可降低发病率并改善长期功能结局。
核心结论
- COVID-19 相关肩带钙化性肌炎是 COVID-19 罕见的肺外肌肉骨骼表现,作者经验认为早期识别和提高认识有助于降低患者发病率并改善长期功能结局。
研究设计与样本
- 回顾性研究,纳入 2020 年 4 月、5 月、2021 年 1 月和 2021 年 7 月在 Queen Alexandra Hospital(Portsmouth Hospitals University NHS Trust,United Kingdom)行 CT 肺动脉造影检查的全部患者,共 1239 次检查、1201 例患者。
关键影像表现/征象
- 钙化性肌炎最常见的部位是肩胛下肌。
诊断标准与关键数值
- 第一波 364 例患者中 71 例(19.5%)患 COVID-19,其中 2 例(2.8%)有肩带钙化性肌炎。
- 第二波 521 例患者中 354 例(67.9%)患 COVID-19,其中 3 例(0.8%)有肩带钙化性肌炎。
- 第三波 316 例患者中 37 例(11.7%)患 COVID-19,其中 1 例(2.7%)有肩带钙化性肌炎。
- 总体患病率为 1.3%。
临床应用与阅片要点
- 作者经验认为早期识别和提高对该疾病实体的认识有助于降低患者发病率并改善长期功能结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the prevalence, describe the radiological features, and consider the clinical sequelae of COVID-19- associated shoulder girdle calcific myositis.
METHODS: All patients who underwent a CT pulmonary angiogram study at our institution (Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom) in April and May 2020, January 2021, and July 2021 were included. A total of 1239 CT pulmonary angiogram studies for 1201 patients were reviewed. Patients with COVID-19 and associated shoulder girdle calcific myositis were identified. Their electronic patient records were reviewed. The patients' demographics, serum inflammatory markers, and proning history were recorded.
RESULTS: Of the 364 patients in Wave 1, 71 patients (19.5%) had COVID-19, and of those, 2 patients (2.8%) had shoulder girdle calcific myositis. Of the 521 patients in Wave 2, 354 patients (67.9%) had COVID-19, and of those, 3 patients (0.8%) had shoulder girdle calcific myositis. Of the 316 patients in Wave 3, 37 patients (11.7%) had COVID-19, and of those, 1 patient (2.7%) had shoulder girdle calcific myositis. The overall prevalence was 1.3%. The most common site of calcific myositis was within the subscapularis muscle.
CONCLUSION: COVID-19-associated shoulder girdle calcific myositis is a rare extrapulmonary musculoskeletal manifestation of COVID-19. Early recognition and increased awareness of this disease entity, in our experience, aids in reducing patient morbidity and improving long-term functional outcome.
ADVANCES IN KNOWLEDGE: We have reported a novel disease entity associated with COVID-19, in the form of shoulder girdle calcific myositis. We have described the common imaging features and discussed our experience of management and clinical sequelae.
引用
- Al-Khudairi, Dulay, Witham, et al. Covid-19 associated shoulder girdle calcific myositis: a novel entity. Br J Radiol. 2022. PMID: 35867893. doi:10.1259/bjr.20220411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。